Vergleich

Western Blot

2624469 Artikel

pro Seite

Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge Preis
Anti-­Human Casp-­4 (NT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1222-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human Casp-­4 (Intermediate Domain) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1221-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CTRP6 (CT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1252-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human Casp-­2 (NT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1220-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CTRP5 (Intermediate Domain) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB LEIN-C1251-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human Casp-­1 (Intermediate Domain) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB LEIN-C1219-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human Casp-­1 (CT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1218-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human Casitas B-­lineage Lymphoma Proto-­Oncogene (Cbl) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB LEIN-C1224-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CARD10 (CT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1215-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CARMA1 -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB LEIN-C1217-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CTRP7 (NT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1255-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CARD8 -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB LEIN-C1216-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CTRP1 (Intermediate Domain) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB LEIN-C1232-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CTRP6 (Intermediate Domain) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1253-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human Caspase-­6 (Intermediate Domain) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1235-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human Caspase-­7 (CT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1238-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CTRP1 (NT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB LEIN-C1233-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CTRP2 (Intermediate Domain) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1234-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CTRP7 (CT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1254-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CTRP2 (NT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB LEIN-C1236-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human Caspase-­6 (NT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1237-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CIDE-­A (CT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, ELISA LEIN-C1146-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CX3CR1 (NT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, FC, IHC LEIN-C1121-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Human CX3CR1 (EL) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB, IHC LEIN-C1120-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Anti-­Mouse CIDE-­B (CT) -­ 20 µg Sicherheitsdatenblatt downloaden Antibody Primary Other WB LEIN-C1111-20ug

Leinco Technologies
20 ug Anmelden
Vergleichen
Name Preis
Anti-­Human Casp-­4 (NT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human Casp-­4 (Intermediate Domain) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CTRP6 (CT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human Casp-­2 (NT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CTRP5 (Intermediate Domain) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human Casp-­1 (Intermediate Domain) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human Casp-­1 (CT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human Casitas B-­lineage Lymphoma Proto-­Oncogene (Cbl) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CARD10 (CT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CARMA1 -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CTRP7 (NT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CARD8 -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CTRP1 (Intermediate Domain) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CTRP6 (Intermediate Domain) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human Caspase-­6 (Intermediate Domain) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human Caspase-­7 (CT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CTRP1 (NT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CTRP2 (Intermediate Domain) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CTRP7 (CT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CTRP2 (NT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human Caspase-­6 (NT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CIDE-­A (CT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, ELISA
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CX3CR1 (NT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, FC, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Human CX3CR1 (EL) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB, IHC
Host
ArtNr.
Menge 20 ug
Lieferbar
Anti-­Mouse CIDE-­B (CT) -­ 20 µg Anmelden
Typ Antibody Primary
Clone
Specific against Other
Appl. WB
Host
ArtNr.
Menge 20 ug
Lieferbar

2624469 Artikel

pro Seite

Eigenschaften

  •   Einfache Durchführung - Schnelles und einfaches Verfahren
  •   Hohe Sensitivität - Die Empfindlichkeit der ONE-HOUR Western ™ Kits sind vergleichbar oder besser als die der klassischen 4,5-Stunden-Verfahren, je nach Qualität und Menge der verwendeten Antikörper.
  •   Reproduzierbare Ergebnisse
  •   Weniger Optimierung nötig als bei der klassische Methode
  •   Sekundärer Antikörper ist enthalten
  •   Keine besondere Markierung des Primärantikörpers erforderlich